Full Text View
Tabular View
No Study Results Posted
Related Studies
Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus Syndrome
This study has been completed.
Study NCT00003601   Information provided by National Cancer Institute (NCI)
First Received: November 1, 1999   Last Updated: July 23, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Melanoma (Skin)
Additional conditions recognized in this trial
Dysplastic Nevus Syndrome
Melanoma
Syndrome
More general conditions related to this trial
Disease
Genetic Diseases, Inborn
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Germ Cell and Embryonal
Neoplasms, Nerve Tissue
Neoplastic Syndromes, Hereditary
Neuroectodermal Tumors
Neuroendocrine Tumors
Nevi and Melanomas
Nevus
Pathologic Processes
Interventions listed in this trial
fenretinide
tretinoin
More general drug interventions related to this trial
Anticarcinogenic Agents
Antineoplastic Agents
Dermatologic Agents
Keratolytic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services